Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline effects on the brain in obsessive-compulsive disorder
RBR-9hpwgjyRecruiting
- Sponsor
- IPq-HCFMUSP
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sertraline in obsessive compulsive disorder (OCD), sponsored by IPq-HCFMUSP. Primary endpoint: Within-participant brain imaging change before and after pharmacologic treatment. Started Jan 2021; status: recruiting.
02
Drugs
sertraline
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on RBR-9hpwgjy.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9hpwgjy.